Drugs · Entity Annotation Prototype (beta)

2articles mentioning drugs

2drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: ATG ×

ATG

This drug is selected. Its supporting articles are shown below.

ATG2

Articles mentioning ATG

2 articles · page 1 of 1

OC.54 Timing matters: early autologous stem cel transplantation shows a lower mortality in high-risk diffuse cutaneous systemic sclerosis – preliminary results from the upside trial

jsrd · abstract · 2026-06-05 · 1 matching annotations

76.8%

mycophenolate mofetil cyclophosphamide CYC ATG Health Assessment Questionnaire Diffuse cutaneous systemic sclerosis (dcSSc)immunosuppressants dcSSc

…onthly CYC pulses (750 mg/m 2) followed by at least one year of mycophenolate mofetil. Criteria for rescue HSCT or DMARD use post-HSCT were predefine…

P.253 Unveiling the storm: prevalence and risk factors for cytokine release syndrome in systemic sclerosis patients undergoing autologous hematopoietic stem cell transplantation

jsrd · abstract · 2026-06-05 · 1 matching annotations

88.0%

tocilizumab eculizumab ATG dcSSc Dutch university hospitals American Society for Transplantation and Cellular Therapy cytokine release syndrome (CRS)diffuse cutaneous systemic sclerosis (dcSSc)CRS

… treated with glucocorticoids, and one patient was treated with tocilizumab and eculizumab. A DLCO <60% of predicted was significantly asso…

Browse drugs

ATG

Articles mentioning ATG

OC.54 Timing matters: early autologous stem cel transplantation shows a lower mortality in high-risk diffuse cutaneous systemic sclerosis – preliminary results from the upside trial

P.253 Unveiling the storm: prevalence and risk factors for cytokine release syndrome in systemic sclerosis patients undergoing autologous hematopoietic stem cell transplantation